53例颅内结核瘤的临床分析

目的　探讨颅内结核瘤的临床特点及抗结核药物治疗的效果。方法 对53例颅内结核瘤病例作了回顾性分析,患者抗结核药物治疗1.5～2年,于疗程结束随访观察0.5～2年。结果 MRI较CT提高了颅内结核瘤的发现率,53例患者的误诊率77.4%,死亡率5.7%,满疗程治愈率84.9%,随访期间无1例复发。结论 颅内结核瘤应早期发现,早期抗结核药物治疗效果好,预后佳。

The clinical analysis on 53 cases with intracranial tuberculoma

Objective To investigate the clinical features of intracranial tuberculoma and its therapeutic effect of antituberculosis drugs. Method A total of 53 cases with intracranial tuberculoma were reviewed.All of them were received 18～24 months anti-tuberculosis chemotherapy and followed-up for 6 to 24 months after of treatment completion. Results MRI in detection of intracranial tuberculomas was superior to CT.The misdiagnostic rate was 77.4%,the death rate was 5.7% and the cure rate 84.9% in 53 cases.None of them relapsed during follow up. Conclusion The intracranial tuberculoma should be recognized at the early stage.The therapeutic Results and its prognosis are excellent when anti-tuberculosis chemotherapy is given in the early phase of disease.